With a growing range of new vaccines coming on to the market and evidence that some countries simply could not sustain the significant increases in funding required to maintain immunisation programmes, GAVI’s first-ever strategy incorporated a detailed review of how best to deploy its growing resources:
Four strategic goals (SG) underpinned Phase II:
SG1: contribute to strengthening the capacity of the health system to deliver immunisation and other health services in a sustainable manner.
SG2: accelerate the uptake and use of underused and new vaccines and associated technologies and improve vaccine supply security.
SG3: increase the predictability and sustainability of long-term financing for national immunisation programmes.
SG4: increase and assess the added value of GAVI as a public-private global health partnership through improved efficiency, increased advocacy and continued innovation
To keep the 2006-2010 strategic plan on track, the Alliance developed a work plan listing activities for 2007, 2008 and 2009-10. With a total budget of US$ 297 million available for the strategy’s four-year life cycle, any given year in the GAVI strategy contained up to 100 activities. To help measure progress, these activities are reported against 17 outputs.